New approach may help design shorter, more powerful trials to evaluate drugs for Parkinson’s disease
Testing whether a new drug has an impact on the progression of Parkinson’s disease takes years, in part because the disease often progresses very slowly. Many patients with Parkinson’s disease experience no worsening of their symptoms during a typical clinical trial, even without treatment. Now Scripps Research scientists have developed a tool that analyzes genetic …